Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q3712521> ?p ?o }
Showing triples 1 to 68 of
68
with 100 triples per page.
- Q3712521 subject Q22230916.
- Q3712521 subject Q8788410.
- Q3712521 subject Q8824860.
- Q3712521 subject Q8965786.
- Q3712521 abstract "Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 µg of dofetilide. It is not available in Europe or Australia.Due to the pro-arrhythmic potential of dofetilide, it is only available by prescription from physicians who have undergone specific training in the risks of treatment with dofetilide. In addition, it is only available by mail order or through specially trained local pharmacies.".
- Q3712521 atcPrefix "C01".
- Q3712521 atcSuffix "BD04".
- Q3712521 bioavailability "96.0".
- Q3712521 casNumber "115256-11-6".
- Q3712521 chEBI "4681".
- Q3712521 drugbank "DB00204".
- Q3712521 fdaUniiCode "R4Z9X1N2ND".
- Q3712521 iupacName "N-[4-(2-{[2-(4-methane sulfonamidophenoxy)ethyl](methyl)amino}ethyl)phenyl]methanesulfonamide".
- Q3712521 pubchem "71329".
- Q3712521 thumbnail Dofetilide.png?width=300.
- Q3712521 wikiPageWikiLink Q11269508.
- Q3712521 wikiPageWikiLink Q12152.
- Q3712521 wikiPageWikiLink Q14864419.
- Q3712521 wikiPageWikiLink Q1506572.
- Q3712521 wikiPageWikiLink Q15070163.
- Q3712521 wikiPageWikiLink Q1542839.
- Q3712521 wikiPageWikiLink Q1625433.
- Q3712521 wikiPageWikiLink Q1645498.
- Q3712521 wikiPageWikiLink Q1729126.
- Q3712521 wikiPageWikiLink Q181754.
- Q3712521 wikiPageWikiLink Q2002035.
- Q3712521 wikiPageWikiLink Q206921.
- Q3712521 wikiPageWikiLink Q209867.
- Q3712521 wikiPageWikiLink Q22230916.
- Q3712521 wikiPageWikiLink Q2359690.
- Q3712521 wikiPageWikiLink Q241549.
- Q3712521 wikiPageWikiLink Q275447.
- Q3712521 wikiPageWikiLink Q2882301.
- Q3712521 wikiPageWikiLink Q30.
- Q3712521 wikiPageWikiLink Q407693.
- Q3712521 wikiPageWikiLink Q407883.
- Q3712521 wikiPageWikiLink Q409492.
- Q3712521 wikiPageWikiLink Q410291.
- Q3712521 wikiPageWikiLink Q411229.
- Q3712521 wikiPageWikiLink Q422665.
- Q3712521 wikiPageWikiLink Q423930.
- Q3712521 wikiPageWikiLink Q426660.
- Q3712521 wikiPageWikiLink Q461809.
- Q3712521 wikiPageWikiLink Q47270.
- Q3712521 wikiPageWikiLink Q476921.
- Q3712521 wikiPageWikiLink Q79785.
- Q3712521 wikiPageWikiLink Q815819.
- Q3712521 wikiPageWikiLink Q8788410.
- Q3712521 wikiPageWikiLink Q8824860.
- Q3712521 wikiPageWikiLink Q8965786.
- Q3712521 wikiPageWikiLink Q9377.
- Q3712521 atcPrefix "1.0".
- Q3712521 atcSuffix "BD04".
- Q3712521 bioavailability "96.0".
- Q3712521 casNumber "115256".
- Q3712521 chebi "4681".
- Q3712521 drugbank "DB00204".
- Q3712521 iupacName "N-[4-phenyl]methanesulfonamide".
- Q3712521 pubchem "71329".
- Q3712521 unii "R4Z9X1N2ND".
- Q3712521 type ChemicalSubstance.
- Q3712521 type Drug.
- Q3712521 type ChemicalObject.
- Q3712521 type Thing.
- Q3712521 type Q8386.
- Q3712521 comment "Dofetilide is a class III antiarrhythmic agent. It is marketed under the trade name Tikosyn by Pfizer, and is available in the United States in capsules containing 125, 250, and 500 µg of dofetilide. It is not available in Europe or Australia.Due to the pro-arrhythmic potential of dofetilide, it is only available by prescription from physicians who have undergone specific training in the risks of treatment with dofetilide.".
- Q3712521 label "Dofetilide".
- Q3712521 depiction Dofetilide.png.